Dental follicle mesenchymal stem cells down-regulate Th2-mediated immune response in asthmatic patients mononuclear cells.


Genc D., Zibandeh N., Nain E., Gokalp M., Ozen A. O., Goker M. K., ...Daha Fazla

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, cilt.48, sa.6, ss.663-678, 2018 (SCI-Expanded) identifier identifier identifier

Özet

BackgroundAsthma is a chronic inflammatory disease in which inflammatory responses have the polarisation of CD4(+) T cells to Th2 cells. Dental follicle mesenchymal stem cells (DFSCs) have strong anti-inflammatory properties comparable to other mesenchymal stem cells.